JENNIFER FOSTER to Dose-Response Relationship, Drug
This is a "connection" page, showing publications JENNIFER FOSTER has written about Dose-Response Relationship, Drug.
Connection Strength
0.386
-
Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Cancer Lett. 2019 08 10; 457:129-141.
Score: 0.121
-
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities. Cancer Chemother Pharmacol. 2019 02; 83(2):349-360.
Score: 0.117
-
Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity. J Pediatr Hematol Oncol. 2017 01; 39(1):72-76.
Score: 0.103
-
A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma. Cancer. 2025 Feb 15; 131(4):e35751.
Score: 0.045